Alopecia areata is a well-established autoimmune disease, but not all types of hair loss (alopecia) are autoimmune. The word “alopecia” simply means hair loss, and it has dozens of causes ranging from hormones to stress to nutritional deficiencies. When most people ask whether alopecia is autoimmune, they’re asking about alopecia areata, the type that causes sudden, often circular patches of hair loss. That form is driven entirely by the immune system attacking hair follicles.
How the Immune System Causes Hair Loss
Hair follicles have a unique feature: during their active growth phase, they operate with a kind of biological invisibility from the immune system. Scientists call this “immune privilege.” The follicle actively suppresses certain surface markers that would otherwise flag it for immune attention, and it produces signals that keep immune cells at bay.
In alopecia areata, that protective barrier collapses. Once the follicle becomes visible to the immune system, a specific type of white blood cell (CD8+ T cells) moves in first and triggers an inflammatory response around the base of the follicle. These cells, along with helper T cells and natural killer cells, produce signaling molecules that disrupt the hair growth cycle, force the follicle into a resting state prematurely, and block new growth from starting. The follicle itself isn’t destroyed, which is why regrowth remains possible, but it can’t produce hair as long as the immune attack continues.
What Alopecia Areata Looks Like
The condition typically starts with a single smooth, round patch of hair loss on the scalp. About 80% of people first notice just one patch. From there, it can stay limited or progress in two directions. Alopecia totalis refers to complete loss of all scalp hair. Alopecia universalis means loss of all body hair, including eyebrows, eyelashes, and body hair. These are not separate diseases but rather points on the same spectrum of autoimmune hair loss.
The patches are usually smooth with no scarring, redness, or flaking, which helps distinguish alopecia areata from other conditions like fungal infections or scarring hair loss disorders. Some people notice short, tapered hairs at the edges of a patch, sometimes called “exclamation point hairs,” which are a hallmark sign.
How It Differs From Common Hair Loss
The most widespread type of hair loss, androgenetic alopecia (pattern baldness), is not autoimmune. It’s driven by hormones called androgens, particularly one called DHT, which gradually shrinks hair follicles over time. In men, this creates the familiar receding hairline and thinning crown. In women, it shows up as overall thinning at the top of the head with a widening part, and it rarely leads to total baldness.
The key differences are pattern and speed. Androgenetic alopecia is slow, predictable, and follows a recognizable shape. Alopecia areata is sudden, patchy, and unpredictable. Pattern baldness gradually produces thinner, shorter hairs before the follicle stops producing visible hair altogether. Alopecia areata causes full-thickness hairs to fall out abruptly, leaving smooth bare spots.
Genetics and Triggers
Alopecia areata has a strong genetic component, though no single gene causes it. Researchers have identified dozens of associated genes, and many of them belong to the HLA complex, a gene family central to immune function. Variations in these genes appear to make the immune system more prone to misidentifying hair follicles as threats. Other implicated genes are involved in inflammation signaling, which helps explain why the immune response, once triggered, can be so persistent.
Having the genetic predisposition doesn’t guarantee you’ll develop the condition. Environmental triggers play a role, though pinning down exactly which ones is difficult. Emotional stress, physical illness, and viral infections are commonly reported before a first episode, but they likely act as catalysts in someone already genetically susceptible rather than as standalone causes.
Links to Other Autoimmune Conditions
People with alopecia areata have a higher incidence of other autoimmune diseases, particularly autoimmune thyroid disease, pernicious anemia (a condition where the immune system impairs vitamin B12 absorption), and celiac disease. This clustering isn’t coincidental. The same genetic variants in immune regulation that predispose someone to alopecia areata can increase susceptibility to other conditions where the immune system targets the body’s own tissues. If you’ve been diagnosed with alopecia areata, thyroid screening is a reasonable conversation to have with your doctor.
Chances of Spontaneous Regrowth
One of the more reassuring aspects of alopecia areata is that the hair follicles remain alive beneath the skin. Unlike scarring forms of hair loss, where follicles are permanently destroyed, alopecia areata follicles can resume normal function once the immune attack subsides. Many people with limited patchy hair loss experience spontaneous regrowth without treatment, sometimes within months. The hair may initially grow back finer or lighter before returning to its normal texture and color.
The more extensive the hair loss, the less likely spontaneous regrowth becomes. People with alopecia totalis or universalis face longer odds of full recovery without intervention, and the condition can cycle through periods of loss and regrowth unpredictably over years.
Treatment With JAK Inhibitors
The understanding of alopecia areata as an autoimmune disease has led directly to targeted treatments. The FDA has approved three medications in a class called JAK inhibitors, which work by blocking the specific inflammatory signaling pathways that drive the immune attack on hair follicles.
Clinical trial results give a realistic picture of what to expect. With baricitinib, about one-third of patients with extensive hair loss achieved 80% or more scalp coverage after 36 weeks. With continued treatment over two years, that number rose to 90%. Deuruxolitinib showed similar early results, with roughly a third of participants reaching 80% coverage at 24 weeks, compared to less than 1% on placebo. Ritlecitinib also demonstrated significantly better regrowth than placebo in trials.
These medications are taken orally and require ongoing use. Hair loss can return if treatment is stopped, since the underlying autoimmune tendency doesn’t go away. They also carry potential side effects related to broader immune suppression, so they’re generally reserved for moderate to severe cases where the hair loss significantly affects quality of life. For milder cases, topical treatments and injections of anti-inflammatory compounds into the scalp remain common first-line approaches.